Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain: A Randomized Multicenter Trial

NCT07202897 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT07202897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain: A Randomized Multicenter Trial
Lead sponsor
Rennes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
January 7, 2026
Completion date
January 7, 2033
Enrollment
532 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy (hcm)